← Back to Search

3D Team Care for Dementia

N/A

Recruiting

Led By Richard H Fortinsky, PhD

Research Sponsored by UConn Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months

Awards & highlights

Study Summary

This trial will test a team care model focused on cognitive vulnerability (the 3Ds) in order to improve outcomes for older adults.

Who is the study for?

This trial is for older adults living at home or in assisted living with dementia, depression, or recent delirium. They should plan to stay local for a year and speak English. It's not for those with schizophrenia/bipolar disorder, bedbound/non-communicative individuals, those expected to live less than a year, or if already in the comparator program.Check my eligibility

What is being tested?

The study tests a Home Based Care Team model led by nurse practitioners against regular telephone check-ins. The goal is to see if this approach reduces hospital visits and improves depression symptoms, disability levels, and overall quality of life.See study design

What are the potential side effects?

Since this trial involves care models rather than medications, traditional side effects are not applicable. However, there may be emotional or psychological impacts from receiving different levels of attention and care.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Proportion hospitalized or used emergency department without hospitalization

Secondary outcome measures

Caregiver Assessment of Function and Upset (CAFU)

Family caregiver perceived well-being

GRID Hamilton Rating Scale for Depression (GRID-HAMD), 17-item version.

Other outcome measures

Center for Epidemiologic Studies-Depression Scale (CES-D)

Neuropsychiatric Inventory (NPI-C)

Quality of Life-Alzheimer's Disease Scale (QOL-AD)

+2 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Home Based Care TeamExperimental Treatment1 Intervention

Primarily in-home treatment provided by team led by nurse practitioner with geriatrics and geriatric psychiatry expertise.

Group II: Telephone Based Care TeamActive Control1 Intervention

Primarily telephone-based treatment provided by existing care management program offered by collaborating Medicare Advantage insurer.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

UConn HealthLead Sponsor

211 Previous Clinical Trials

60,045 Total Patients Enrolled

3 Trials studying Dementia

791 Patients Enrolled for Dementia

Patient-Centered Outcomes Research InstituteOTHER

551 Previous Clinical Trials

29,996,872 Total Patients Enrolled

6 Trials studying Dementia

51,774 Patients Enrolled for Dementia

University of ConnecticutOTHER

184 Previous Clinical Trials

157,717 Total Patients Enrolled

Media Library

Home Based Care Team Clinical Trial Eligibility Overview. Trial Name: NCT02945085 — N/A

Dementia Research Study Groups: Home Based Care Team, Telephone Based Care Team

Dementia Clinical Trial 2023: Home Based Care Team Highlights & Side Effects. Trial Name: NCT02945085 — N/A

Home Based Care Team 2023 Treatment Timeline for Medical Study. Trial Name: NCT02945085 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the cumulative figure of participants involved in this research?

"Affirmative. In accordance with the data hosted on clinicaltrials.gov, this medical study is still open for recruitment and was initially posted on March 6th 2017. 956 participants are required to be recruited from one site in order to complete this trial."

Answered by AI

Are there any available slots in this research to participate?

"This clinical trial, according to information published on clinicaltrials.gov, is currently enlisting participants. It was initially posted in March of 2017 and amended most recently in March of 2022."

Answered by AI

Recent research and studies

Contemporary Clinical TrialsJournal

Clinical Trial Testing In-home Multidisciplinary Care Management for Older Adults with Cognitive Vulnerability: Rationale and Study Design

Fortinsky, Richard H., George A. Kuchel, David C. Steffens, James Grady, Marie Smith, and Julie T. Robison. 2020. “Clinical Trial Testing In-home Multidisciplinary Care Management for Older Adults with Cognitive Vulnerability: Rationale and Study Design”. Contemporary Clinical Trials. Elsevier BV. doi:10.1016/j.cct.2020.105992.

Drugs & AgingJournal

Pharmacist Identification of Medication Therapy Problems Involving Cognition Among Older Adults Followed by a Home-based Care Team

Levine, Allison M. P., Erin E. Emonds, Marie A. Smith, Nathaniel M. Rickles, George A. Kuchel, David C. Steffens, Alis Ohlheiser, and Richard H. Fortinsky. 2020. “Pharmacist Identification of Medication Therapy Problems Involving Cognition Among Older Adults Followed by a Home-based Care Team”. Drugs & Aging. Springer Science and Business Media LLC. doi:10.1007/s40266-020-00821-7.

clinicaltrials.govStudy

3D Team Care for Cognitively Vulnerable Older Adults

Fortinsky, Richard 2017. "3D Team Care for Cognitively Vulnerable Older Adults". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02945085.

All > Depression New York > Treatment Resistant Depression